|
|
|
Insider
Information: |
Shandell Jason B. |
Relationship: |
President and General ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
179,276 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$7,171,040 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
179,276 |
|
|
Total
Value |
$7,171,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Amphastar Pharmaceuticals, Inc. |
AMPH |
President and General ... |
2020-03-17 |
179,276 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-03-26 |
4 |
D |
$18.61 |
$83,596 |
D/D |
(4,492) |
220,394 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2016-08-17 |
4 |
AS |
$18.86 |
$112,909 |
D/D |
(5,987) |
202,961 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-12-18 |
4 |
AS |
$19.13 |
$156,958 |
D/D |
(8,205) |
138,898 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-01-25 |
4 |
AS |
$19.26 |
$166,822 |
D/D |
(8,661) |
226,914 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-03-19 |
4 |
AS |
$19.37 |
$226,767 |
D/D |
(11,707) |
233,179 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2016-09-26 |
4 |
AS |
$19.50 |
$1,111,268 |
D/D |
(56,996) |
202,961 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-03-20 |
4 |
AS |
$19.52 |
$161,871 |
D/D |
(8,293) |
224,886 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-01-26 |
4 |
AS |
$19.56 |
$194,925 |
D/D |
(9,966) |
216,948 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2020-02-05 |
4 |
AS |
$19.57 |
$305,554 |
D/D |
(15,615) |
138,898 |
0 |
% |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2020-02-06 |
4 |
AS |
$19.83 |
$434,951 |
D/D |
(21,933) |
138,898 |
0 |
% |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2020-02-07 |
4 |
AS |
$19.88 |
$136,260 |
D/D |
(6,853) |
138,898 |
0 |
% |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-03-16 |
4 |
D |
$19.91 |
$109,405 |
D/D |
(5,495) |
251,372 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-03-17 |
4 |
D |
$19.91 |
$129,136 |
D/D |
(6,486) |
244,886 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2016-08-22 |
4 |
AS |
$19.95 |
$199,500 |
D/D |
(10,000) |
202,961 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-03-15 |
4 |
D |
$20.23 |
$106,309 |
D/D |
(5,255) |
194,285 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-03-16 |
4 |
D |
$20.23 |
$169,548 |
D/D |
(8,381) |
185,904 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-03-17 |
4 |
D |
$20.23 |
$199,791 |
D/D |
(9,876) |
176,028 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-03-01 |
4 |
OE |
$20.26 |
$151,950 |
D/D |
7,500 |
175,818 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-07-10 |
4 |
AS |
$20.31 |
$134,333 |
D/D |
(6,615) |
154,443 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-03-15 |
4 |
AS |
$20.34 |
$498,441 |
D/D |
(24,508) |
160,490 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-03-14 |
4 |
AS |
$20.37 |
$159,489 |
D/D |
(7,828) |
160,490 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-03-13 |
4 |
AS |
$20.45 |
$6,135 |
D/D |
(300) |
216,948 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2018-03-14 |
4 |
AS |
$20.45 |
$8,180 |
D/D |
(400) |
216,948 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2016-11-28 |
4 |
AS |
$20.47 |
$497,201 |
D/D |
(24,292) |
202,961 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
|
2019-03-26 |
4 |
D |
$20.54 |
$135,626 |
D/D |
(6,603) |
169,425 |
0 |
- |
|
85 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|